脂蛋白(a) 与心血管疾病风险关系及临床管理的专家科学建议

2021-12-15 北京心脏学会中国循环杂志

脂蛋白(a) [Lp(a)] 升高是动脉粥样硬化性心血管疾病（ASCVD）包括冠心病、缺血性脑卒中、外围血管疾病及钙化性主动脉瓣狭窄等疾病的独立危险因素。

中文标题：

发布机构：

北京心脏学会

发布日期：

2021-12-15

简要介绍：

脂蛋白(a) [Lp(a)] 升高是动脉粥样硬化性心血管疾病（ASCVD）包括冠心病、缺血性脑卒中、外围血管疾病及钙化性主动脉瓣狭窄等疾病的独立危险因素。研究证实，即使有效降低低密度脂蛋白胆固醇（LDL-C）水平，Lp(a) 仍会增加未来ASCVD 的风险。然而，有关Lp(a) 检测、检测人群、风险增加切点及治疗推荐尚存在诸多困惑。据此，本建议结合中国人群有关Lp(a) 的研究证据及国外文献，对Lp(a) 的诸多方面进行全面而科学阐述，以期为我国医务工作者提供参考。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=0ec231c0023080ff, title=脂蛋白(a) 与心血管疾病风险关系及临床管理的专家科学建议, enTitle=, guiderFrom=中国循环杂志, authorId=0, author=, summary=脂蛋白(a) [Lp(a)] 升高是动脉粥样硬化性心血管疾病（ASCVD）包括冠心病、缺血性脑卒中、外围血管疾病及钙化性主动脉瓣狭窄等疾病的独立危险因素。, cover=https://img.medsci.cn/20211229/1640752385697_5579292.jpg, journalId=0, articlesId=null, associationId=2266, associationName=北京心脏学会, associationIntro=北京心脏学会, copyright=0, guiderPublishedTime=Wed Dec 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=脂蛋白(a) [Lp(a)] 升高是动脉粥样硬化性心血管疾病（ASCVD）包括冠心病、缺血性脑卒中、外围血管疾病及钙化性主动脉瓣狭窄等疾病的独立危险因素。研究证实，即使有效降低低密度脂蛋白胆固醇（LDL-C）水平，Lp(a) 仍会增加未来ASCVD 的风险。然而，有关Lp(a) 检测、检测人群、风险增加切点及治疗推荐尚存在诸多困惑。据此，本建议结合中国人群有关Lp(a) 的研究证据及国外文献，对Lp(a) 的诸多方面进行全面而科学阐述，以期为我国医务工作者提供参考。, tagList=[TagDto(tagId=2529, tagName=心血管疾病), TagDto(tagId=15124, tagName=脂蛋白a)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=25541, guiderKeyword=脂蛋白（a）[Lp（a）], guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2563, appHits=127, showAppHits=0, pcHits=929, showPcHits=2431, likes=2, shares=21, comments=3, approvalStatus=1, publishedTime=Wed Dec 29 12:29:33 CST 2021, publishedTimeString=2021-12-15, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Dec 29 12:33:23 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 02:45:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=脂蛋白(a)与心血管疾病风险关系及临床管理的专家科学建议.pdf)])

脂蛋白(a)与心血管疾病风险关系及临床管理的专家科学建议.pdf

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1186531, encodeId=f2361186531aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Thu Jan 20 18:27:11 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179913, encodeId=9ad311e9913bb, content=脂蛋白a高到什么程度需要药物干预？影响检测结果因素是什么？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4656413897, createdName=ms9000001961527103, createdTime=Mon Jan 03 06:03:23 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085677, encodeId=935510856e79b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 30 06:56:04 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2022-01-20 ms6000000225486324

学习了

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1186531, encodeId=f2361186531aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Thu Jan 20 18:27:11 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179913, encodeId=9ad311e9913bb, content=脂蛋白a高到什么程度需要药物干预？影响检测结果因素是什么？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4656413897, createdName=ms9000001961527103, createdTime=Mon Jan 03 06:03:23 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085677, encodeId=935510856e79b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 30 06:56:04 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2022-01-03 ms9000001961527103

脂蛋白a高到什么程度需要药物干预？影响检测结果因素是什么？

59 0
[GetPortalCommentsPageByObjectIdResponse(id=1186531, encodeId=f2361186531aa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Thu Jan 20 18:27:11 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179913, encodeId=9ad311e9913bb, content=脂蛋白a高到什么程度需要药物干预？影响检测结果因素是什么？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4656413897, createdName=ms9000001961527103, createdTime=Mon Jan 03 06:03:23 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085677, encodeId=935510856e79b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 30 06:56:04 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
2021-12-30 微探

学习学习

58 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

脂蛋白(a) 与心血管疾病风险关系及临床管理的专家科学建议

相关指南

科室

工具

服务